Targeted review of IL36RN mutations in patients with generalised pustular psoriasis
Abstract Background Generalised pustular psoriasis (GPP) is a rare and chronic skin disease historically treated with therapies that were originally intended to treat plaque psoriasis (PsO). However, GPP and plaque PsO have distinct pathogeneses and clinical courses. Objectives This study aimed to f...
Saved in:
Main Authors: | James G. Krueger (Author), Anna Pagotto (Author), Samuel Haftel (Author), Birgit Gradl (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lack of association between mutation in IL36RN and palmoplantar pustular psoriasis in Chinese patients,
by: Yu Xiaoling, et al.
Published: (2020) -
The utility of IL36RN mutation analysis in an elderly patient with generalized pustular psoriasis patient treated with secukinumab
by: Satoko Minakawa, et al.
Published: (2023) -
Treatment responses of four different biologics in a patient with recurrent generalized pustular psoriasis harboring IL36RN mutation
by: Chang-Yu Hsieh, et al.
Published: (2024) -
Acrodermatitis continua of hallopeau evolving into generalised pustular psoriasis
by: Poovanur SS Ranugha, et al.
Published: (2013) -
Acute Generalised Pustular Psoriasis (Von Zumbusch Type)
by: Malik A.K, et al.
Published: (1998)